Nicolas Arroyo, the chief executive of Vantari Genetics, has pleaded guilty in a genetic testing kickback scheme, the Los Angeles Times' Daily Pilot reports.
The Pilot reports that Arroyo pleaded guilty in a Texas court this week to conspiracy to defraud the United States. According to the Texarkana Gazette, Arroyo and 11 others had been indicted for violating a federal law prohibiting the receival of kickbacks for medical services. This, the Pilot adds, involved referrals to conduct pharmacogenetic testing and, according to the Gazette, Medicare patients.
The Pilot adds that Arroyo has now pleaded guilty and faces up to five years in prison.